SPOTLIGHT -
Dr. Jun on the Results of a Study Investigating Cyptogenic Hepatocellular Carcinoma
Tomi Jun, MD, Stanford University School of Medicine, discusses results of a multi-center study investigating patients with cyptogenic hepatocellular carcinoma (HCC).
Read More
Dr. Jun Discusses Cyptogenic Hepatocellular Carcinoma
Tomi Jun, MD, Stanford University School of Medicine, discusses cryptogenic hepatocellular carcinoma.
Dr. Jun on Results of Study in Cryptogenic Hepatocellular Carcinoma
Tomi Jun, MD, Stanford University School of Medicine, discusses the results of a study of cirrhosis and long-term survival in patients with cryptogenic hepatocellular carcinoma.
Efficacy and Safety of Abemaciclib Plus ET Is Maintained Older Patients with HR+, HER2–, Early Breast Cancer
Retrospective Study Confirms Real-World Efficacy of Brexucabtagene Autoleucel in R/R B-ALL
Dr Garcia-Manero on Luspatercept in Lower-Risk MDS
Dr Zeidan on Imetelstat in Lower-risk MDS
